Document is current
Any future updates will be listed below
-
Authors
Ristuccia, Robert
Zhao, Yang
Chang, Chunlan
Zhou, Huanxue
Takahashi, Takeshi
Nomura, Takanobu
Dennis, Eslie
Akilov, Oleg
-
Funding
Funding for this research was provided by:
Kyowa Kirin Pharmaceutical Development
- License Information
-
More Information
Article History
Received: 11 June 2024
Accepted: 28 August 2024
First Online: 21 September 2024
Declarations
:
: Robert Ristuccia, Chunlan Chang, and Eslie Dennis are salaried employees of Kyowa Kirin, Inc. Yang Zhao was a salaried employee of Kyowa Kirin, Inc. at the time of this work, and is currently a salaried employee of Axsome Therapeutics, Inc. Huanxue Zhou is a salaried employee of KMK Consulting, which was engaged by Kyowa Kirin, Inc. to conduct the study analyses. Takeshi Takahashi and Takanobu Nomura are salaried employees of Kyowa Kirin Co., Ltd. Oleg Akilov has received consultation/advisory fees, funding/grants, and speaking and lecture fees from Kyowa Kirin, Inc.
: This study was a non-interventional, retrospective analysis involving de-identified claims data, and therefore did not require ethical review nor informed consent. The study was performed in accordance with the Helsinki Declaration of 1964 and its later amendments.
